In cancer research, in vitro models are important tools for conducting tumor biology research and drug development. Traditional two-dimensional cell culture has been widely used in basic research, but there are differences between the planar culture environment and the three-dimensional tissue structure formed by tumors in vivo. The spatial arrangement, organization, and interaction of tumor cells with the surrounding microenvironment may affect the study of tumor biology. With the development of 3D culture technology and organoid technology, 3D Cancer Models have gradually become an important model choice in cancer research.
Compared with traditional 2D cell culture, 3D models can provide a culture environment that more closely resembles tissue conditions. Among them, cancer organoids can present the structure, molecular characteristics, and heterogeneity of tumor tissue to a certain extent. Related studies also regard 3D organoid models as a research path connecting two-dimensional in vitro cell models and animal models, providing a new model choice between cancer basic research and treatment research.
3D Cancer Model Development Needs to Match the Specific Research Purpose
3D cancer models encompass a range of model systems. Model development can be tailored to tumor type, study purpose, and model source. Alfa Cytology’s 3D Cancer Model Development service covers multiple approaches to tumor organoid development. Model sources include patient-derived tissues, induced pluripotent stem cells (iPSCs), adult stem cells, patient-derived xenograft models (PDX), circulating tumor cells, embryonic stem cells, and cell lines.
Models from different sources can be used in different research scenarios. For example, patient-derived organoids can be used in studies that preserve specific tumor-associated features, whereas models based on cell lines or other sources can be used in specific experimental systems. In addition to sources, the types of models are also being enriched, including genetically engineered tumor organoids, tumor organoid chips, bio-printed tumor organoids, and tumor organoid co-culture models. Some co-culture systems can also combine immune cells, cancer-associated fibroblasts, or vascular-related components to observe the relationship between tumors and their microenvironment.
This selection of model sources and types according to research objectives enables 3D models to be applied to different cancer research questions rather than being limited to a single cell culture scenario.
Model Characterization Is Also an Important Part of 3D Tumor Research
For 3D cancer models, model development is only one part of the research process. Whether the model has the biological characteristics needed for the study needs to be evaluated through appropriate characterization methods.
The related services of Alfa Cytology include organoid morphological analysis, histological analysis, molecular characterization analysis, functional evaluation, and viability testing. Morphological analysis mainly focuses on the three-dimensional structure and cell arrangement of organoids. Histological analysis is used to observe tissue characteristics and marker expression. Molecular analysis can be used to understand model characteristics at the genome, transcriptome, and proteome levels. In addition, functional assessment and viability assays can be used to observe disease-related functions as well as model responses under different treatment conditions.
For projects involving subsequent drug studies, such characterization can provide further information about the research applicability of the model and help connect model development with subsequent experiments.
Application of 3D Cancer Models in Drug Research
One reason 3D Cancer Models have attracted attention is their application in cancer drug research. Cancer organoids can be used for new drug discovery and validation, as well as for drug screening, drug resistance studies, and efficacy evaluation.
In basic research, cancer organoids can be used to study the interaction between tumors and their microenvironment, as well as the biological processes related to cancer initiation and progression. Based on different research needs, treatment-sensitive and treatment-resistant tumor organoids can also be established to observe model responses under different treatment conditions. Related research also involves immuno-oncology, molecular biology, tumorigenesis and metastasis, cancer progression, and metabolism.
In preclinical studies, organoid-based research services can be further used for drug screening, drug resistance testing, efficacy evaluation, pharmacokinetic studies, and drug toxicity testing. From this perspective, the application of 3D models has gradually extended from model construction to multiple areas of cancer biology research and drug development.
3D Tumor Model Services and Cancer Research Needs
As cancer research becomes more specialized, model requirements have expanded beyond basic cell culture to include model development, characterization, and downstream applications. 3D Tumor Model Services therefore need to consider the matching between tumor type, model source, model form, and specific research purposes.
For research institutions and drug development teams, choosing an appropriate 3D model is not simply a matter of converting two-dimensional culture to three-dimensional culture. The source, type, and subsequent evaluation methods of the model need to be determined according to the research question. Alfa Cytology currently provides services related to the development and characterization of 3D cancer models, covering tumor biology, tumor microenvironment, immuno-oncology, drug screening, drug resistance testing, and efficacy evaluation.
From two-dimensional cell cultures to organoids and other three-dimensional models, cancer researchers now have a broader range of in vitro model options. 3D models cannot simply replace all traditional research models, but they provide different experimental perspectives for studying tissue structure, tumor heterogeneity, and the microenvironment. With the continued application of 3D Cancer Model Development and related characterization techniques, such models provide additional tools for cancer biology research and drug discovery.